Detailed answers about IRAQI PHARMACEUTICAL ACADEMY LTD, including incorporation, status, business activity, and accounts information.
When was IRAQI PHARMACEUTICAL ACADEMY LTD founded?
IRAQI PHARMACEUTICAL ACADEMY LTD was officially incorporated on 16 February 2026 and is registered under company number 17034822. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is IRAQI PHARMACEUTICAL ACADEMY LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of IRAQI PHARMACEUTICAL ACADEMY LTD?
IRAQI PHARMACEUTICAL ACADEMY LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does IRAQI PHARMACEUTICAL ACADEMY LTD do?
IRAQI PHARMACEUTICAL ACADEMY LTD operates in the following sectors: 70229 - Management consultancy activities other than financial management, 72200 - Research and experimental development on social sciences and humanities, 82302 - Activities of conference organisers, 85590 - Other education n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is IRAQI PHARMACEUTICAL ACADEMY LTD's registered address?
The registered office address of IRAQI PHARMACEUTICAL ACADEMY LTD is 86-90 PAUL STREET, LONDON, GREATER LONDON, ENGLAND, EC2A 4NE. This is the official address filed with Companies House for legal and statutory correspondence.
Is IRAQI PHARMACEUTICAL ACADEMY LTD financially stable?
Financial accounts for IRAQI PHARMACEUTICAL ACADEMY LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.